Stay updated on AK104 Plus Anlotinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 Plus Anlotinib in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added to the version history, and the entry for v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:12:53.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The history now includes a new revision v3.5.0 and removes the previous revision v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-25T20:14:37.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The history shows a new release entry for v3.4.3 and removes the previous v3.4.2 entry.
    Difference
    0.1%
    Check dated 2026-03-11T14:24:32.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the record history; the funding notice and the prior Revision v3.4.1 entry were removed.
    Difference
    0.9%
    Check dated 2026-02-11T02:05:56.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page adds a site-wide funding notice banner. It also records a new revision (v3.4.1) in the history, replacing the previous v3.4.0.
    Difference
    0.9%
    Check dated 2026-02-03T22:53:53.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Glossary display and color-coded change indicators (green for additions, red for deletions) were added to the Record History page. The revision banner now shows Revision: v3.4.0, replacing the previous version.
    Difference
    1%
    Check dated 2026-01-27T19:56:01.000Z thumbnail image

Stay in the know with updates to AK104 Plus Anlotinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.